COVID-19 vaccine candidate from China's CNBG promising in human test, says study |
Journal Updates
eMediNexus Coverage from: 
COVID-19 vaccine candidate from China's CNBG promising in human test, says study

0 Read Comments                

One of China’s COVID-19 vaccine candidates has been found to be safe and evoked immune responses in a combined early and mid-stage test in humans, noted researchers.The potential vaccine, BBIBP-CorV, being developed by the Beijing Institute of Biological Products, a subsidiary of China National Biotec Group (CNBG), has already received approval for an emergency inoculation program in China which targets essential workers and other limited groups of people having a high infection risk. Whet...
To read the complete article ,
create a free account.
Sign Up to instantly read 30000+ free Articles & 1000+ Case Studies
Create Account

Already registered?

Login Now